<DOC>
	<DOCNO>NCT02704507</DOCNO>
	<brief_summary>A randomized , split-face , placebo-controlled , double-blind , single-center clinical trial compare topical retinoid half face retinoid plus topical steroid half .</brief_summary>
	<brief_title>Addition Topical Steroid Topical Retinoid Acne Patients</brief_title>
	<detailed_description>A randomized , split-face , placebo-controlled , double-blind , single-center clinical trial wherein 20 patient receive daily 0.05 % tretinoin one half face receive triamcinolone 0.025 % half inert emollient 4 week . Subjects continue apply tretinoin 0.05 % daily bilateral face without triamcinolone emollient additional 4 week . Investigator 's Global Assessment , lesion count , study subject 's self-assessments burning/stinging , itching , erythema , dryness/scaling collect 1 , 2 , 4 , 8 week .</detailed_description>
	<mesh_term>Tretinoin</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<mesh_term>Emollients</mesh_term>
	<criteria>Fitzpatrick skin type I , II , III Will ability discontinue use topical medicine face study duration Capability understand provide inform consent Use oral retinoids within previous 6 month Use corticosteroid face systemic corticosteroid within previous 4 week Any additional facial skin condition ( i.e. , rosacea , seborrheic dermatitis , etc . ) Female participant pregnant , nursing , plan pregnancy participate study Hypersensitivity ingredient study formulation Existence underlie condition investigator feel would hinder participant 's ability complete study appropriately follow direction</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>tretinoin</keyword>
	<keyword>topical steroid</keyword>
	<keyword>irritation</keyword>
	<keyword>retinoid induce irritation</keyword>
</DOC>